Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Report

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Report

Regular price $99.00 Sale price $49.00
/

Please note that these reports are recommended only for Whole Genome Test with 30X and up coverage

(Not compatible with WGL Longreads sequencing test)

 

The Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Report is based on Whole Genome Sequencing Test. As such, it analyzes all Common and Rare Variants associated with Catecholaminergic Polymorphic Ventricular Tachycardia instead of a limited set of genes, like old genetic target panels. 

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a condition characterized by an abnormal heart rhythm (arrhythmia).

Along with environmental factors, Genetics plays a key role in the regulation of Catecholaminergic Polymorphic Ventricular Tachycardia.

 

Click here to see what your report will look like

 

  • 9 genes analyzed
  • 100% genomic regions covered
  • Intragenic and intergenic regions analyzed
  • All variants reported

 

List of genes:

ANK2,CALM1,CALM2,CALM3,CASQ2,KCNJ2,RYR2,TECRL,TRDN